Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

More than half of depression patients give up their treatment

23.11.2010
Most patients who take anti-depressants give up their treatment in less than six months, the minimum period recommended for treating severe depression and other derived pathologies. This is the conclusion of a new study carried out by Catalan researchers, which reveals that only 25% continue their treatment for more than 11 months.

"Only one in every five patients properly completes their treatment", Catalina Serna, co-author of the study, and an expert at the Jordi Gol Primary Care Research Institute (IDIAP) in Lleida, tells SINC.

From 2003 to 2007, researchers from the Catalan Institute of Health (ICS) and the IDIAP Jordi Gol analysed 7,525 patients who were starting anti-depression treatment, looking at how long they continued with this treatment and the reasons why they gave it up.

The results, published this year in the journal European Psychiatry, pointed out that, of the 3.2% of the population who started treatment for depression, 56% stopped taking their medication during the first four months, and less than 25% of the cohort continued their treatment for more than 11 months.

The researchers say patients are most likely to give up their medication during the acute stage of depression (the first months). "The levels to which they stick to their treatment also declines steeply between the first four and 12 months of the monitoring period", Serna points out.

"In our study, only 22% of patients completed their treatment", the expert explains. "The higher completion rates seen in chronic cases are in multiply-medicated patients, who are twice as likely as other patients to continue with their treatment for depression (31% vs. 15.3%).

Men are more likely to give up treatment

Meanwhile, men are more at risk of giving up their treatment earlier than women (50% of men gave up their medication after two months, while 50% of women gave it up after three months).

Depression is one of the commonest psychiatric diseases among adults, above all in industrialised countries. A European study carried out in 2004 found that almost 13% of individuals surveyed reported having a serious depressive illness at some point in their lives. This study revealed that in Spain, where anti-depressant use has risen in line with the availability of new drugs, 10.5% of the population suffers from depression.

References:

M. Catalina Serna, Inés Cruz, Jordi Real, Eduardo Gascó, Leonardo Galván. "Duration and adherence of anti-depressant treatment (2003 to 2007) based on prescription data base". European Psychiatry , 25 (2010) 206-213, mayo de 2010.

Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. "Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project." Acta Psychiatr Scand Suppl 2004

SINC | EurekAlert!
Further information:
http://wwwplataformasinc.es

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Structured light and nanomaterials open new ways to tailor light at the nanoscale

23.04.2018 | Physics and Astronomy

On the shape of the 'petal' for the dissipation curve

23.04.2018 | Physics and Astronomy

Clean and Efficient – Fraunhofer ISE Presents Hydrogen Technologies at the HANNOVER MESSE 2018

23.04.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>